1-[5-(4-ethylpiperazin-1-yl)-1,3,4-thiadiazol-2-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;1-[3-(4-ethylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1,3-oxazol-5-yl]hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[3-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one

C93H121F6N21O5S — CID 158616965

IUPAC1-[5-(4-ethylpiperazin-1-yl)-1,3,4-thiadiazol-2-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;1-[3-(4-ethylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1,3-oxazol-5-yl]hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[3-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one
SMILESCCCC(CC(=O)c1cnc(N2CCN(CC(F)(F)F)CC2)o1)Cc1c[nH]c2ccccc12.CCCC(CC(=O)c1nc(N2CCN(CC(F)(F)F)CC2)n[nH]1)Cc1c[nH]c2ccccc12.CCCC(CC(=O)c1nc(N2CCN(CC)CC2)n[nH]1)Cc1c[nH]c2ccccc12.CCCC(CC(=O)c1nnc(N2CCN(CC)CC2)s1)Cc1c[nH]c2ccccc12
InChIInChI=1S/C24H29F3N4O2.C23H29F3N6O.C23H32N6O.C23H31N5OS/c1-2-5-17(12-18-14-28-20-7-4-3-6-19(18)20)13-21(32)22-15-29-23(33-22)31-10-8-30(9-11-31)16-24(25,26)27;1-2-5-16(12-17-14-27-19-7-4-3-6-18(17)19)13-20(33)21-28-22(30-29-21)32-10-8-31(9-11-32)15-23(24,25)26;1-3-7-17(14-18-16-24-20-9-6-5-8-19(18)20)15-21(30)22-25-23(27-26-22)29-12-10-28(4-2)11-13-29;1-3-7-17(14-18-16-24-20-9-6-5-8-19(18)20)15-21(29)22-25-26-23(30-22)28-12-10-27(4-2)11-13-28/h3-4,6-7,14-15,17,28H,2,5,8-13,16H2,1H3;3-4,6-7,14,16,27H,2,5,8-13,15H2,1H3,(H,28,29,30);5-6,8-9,16-17,24H,3-4,7,10-15H2,1-2H3,(H,25,26,27);5-6,8-9,16-17,24H,3-4,7,10-15H2,1-2H3
InChIKeyHXMYHLWYJSRIQF-UHFFFAOYSA-N
MW1759.19 g/mol
LogP17.33
Rot. Bonds36

About 1-[5-(4-ethylpiperazin-1-yl)-1,3,4-thiadiazol-2-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;1-[3-(4-ethylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1,3-oxazol-5-yl]hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[3-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one

1-[5-(4-ethylpiperazin-1-yl)-1,3,4-thiadiazol-2-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;1-[3-(4-ethylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1,3-oxazol-5-yl]hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[3-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one (PubChem CID 158616965) has the molecular formula C93H121F6N21O5S and a molecular weight of 1759.19 g/mol. Its IUPAC name is 1-[5-(4-ethylpiperazin-1-yl)-1,3,4-thiadiazol-2-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;1-[3-(4-ethylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1,3-oxazol-5-yl]hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[3-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one.

Molecular Properties

Compound Name1-[5-(4-ethylpiperazin-1-yl)-1,3,4-thiadiazol-2-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;1-[3-(4-ethylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1,3-oxazol-5-yl]hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[3-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one
PubChem CID158616965
Molecular FormulaC93H121F6N21O5S
Molecular Weight1759.19 g/mol
Exact Mass1757.95
IUPAC Name1-[5-(4-ethylpiperazin-1-yl)-1,3,4-thiadiazol-2-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;1-[3-(4-ethylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1,3-oxazol-5-yl]hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[3-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one
SMILESCCCC(CC(=O)c1cnc(N2CCN(CC(F)(F)F)CC2)o1)Cc1c[nH]c2ccccc12.CCCC(CC(=O)c1nc(N2CCN(CC(F)(F)F)CC2)n[nH]1)Cc1c[nH]c2ccccc12.CCCC(CC(=O)c1nc(N2CCN(CC)CC2)n[nH]1)Cc1c[nH]c2ccccc12.CCCC(CC(=O)c1nnc(N2CCN(CC)CC2)s1)Cc1c[nH]c2ccccc12
InChIInChI=1S/C24H29F3N4O2.C23H29F3N6O.C23H32N6O.C23H31N5OS/c1-2-5-17(12-18-14-28-20-7-4-3-6-19(18)20)13-21(32)22-15-29-23(33-22)31-10-8-30(9-11-31)16-24(25,26)27;1-2-5-16(12-17-14-27-19-7-4-3-6-18(17)19)13-20(33)21-28-22(30-29-21)32-10-8-31(9-11-32)15-23(24,25)26;1-3-7-17(14-18-16-24-20-9-6-5-8-19(18)20)15-21(30)22-25-23(27-26-22)29-12-10-28(4-2)11-13-29;1-3-7-17(14-18-16-24-20-9-6-5-8-19(18)20)15-21(29)22-25-26-23(30-22)28-12-10-27(4-2)11-13-28/h3-4,6-7,14-15,17,28H,2,5,8-13,16H2,1H3;3-4,6-7,14,16,27H,2,5,8-13,15H2,1H3,(H,28,29,30);5-6,8-9,16-17,24H,3-4,7,10-15H2,1-2H3,(H,25,26,27);5-6,8-9,16-17,24H,3-4,7,10-15H2,1-2H3
InChIKeyHXMYHLWYJSRIQF-UHFFFAOYSA-N
XLogP17.33
TPSA292.31 Ų
H-Bond Donors6
H-Bond Acceptors21
Rotatable Bonds36
Heavy Atoms126
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001759.19
LogP ≤ 517.33
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1021

Analyze 1-[5-(4-ethylpiperazin-1-yl)-1,3,4-thiadiazol-2-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;1-[3-(4-ethylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1,3-oxazol-5-yl]hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[3-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[5-(4-ethylpiperazin-1-yl)-1,3,4-thiadiazol-2-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;1-[3-(4-ethylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1,3-oxazol-5-yl]hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[3-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one?
The IUPAC name of 1-[5-(4-ethylpiperazin-1-yl)-1,3,4-thiadiazol-2-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;1-[3-(4-ethylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1,3-oxazol-5-yl]hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[3-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one (CID 158616965) is 1-[5-(4-ethylpiperazin-1-yl)-1,3,4-thiadiazol-2-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;1-[3-(4-ethylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1,3-oxazol-5-yl]hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[3-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one.
What is the SMILES notation for 1-[5-(4-ethylpiperazin-1-yl)-1,3,4-thiadiazol-2-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;1-[3-(4-ethylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1,3-oxazol-5-yl]hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[3-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one?
The canonical SMILES for 1-[5-(4-ethylpiperazin-1-yl)-1,3,4-thiadiazol-2-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;1-[3-(4-ethylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1,3-oxazol-5-yl]hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[3-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one is CCCC(CC(=O)c1cnc(N2CCN(CC(F)(F)F)CC2)o1)Cc1c[nH]c2ccccc12.CCCC(CC(=O)c1nc(N2CCN(CC(F)(F)F)CC2)n[nH]1)Cc1c[nH]c2ccccc12.CCCC(CC(=O)c1nc(N2CCN(CC)CC2)n[nH]1)Cc1c[nH]c2ccccc12.CCCC(CC(=O)c1nnc(N2CCN(CC)CC2)s1)Cc1c[nH]c2ccccc12.
What is the InChIKey of 1-[5-(4-ethylpiperazin-1-yl)-1,3,4-thiadiazol-2-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;1-[3-(4-ethylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1,3-oxazol-5-yl]hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[3-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one?
The InChIKey is HXMYHLWYJSRIQF-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H29F3N4O2.C23H29F3N6O.C23H32N6O.C23H31N5OS/c1-2-5-17(12-18-14-28-20-7-4-3-6-19(18)20)13-21(32)22-15-29-23(33-22)31-10-8-30(9-11-31)16-24(25,26)27;1-2-5-16(12-17-14-27-19-7-4-3-6-18(17)19)13-20(33)21-28-22(30-29-21)32-10-8-31(9-11-32)15-23(24,25)26;1-3-7-17(14-18-16-24-20-9-6-5-8-19(18)20)15-21(30)22-25-23(27-26-22)29-12-10-28(4-2)11-13-29;1-3-7-17(14-18-16-24-20-9-6-5-8-19(18)20)15-21(29)22-25-26-23(30-22)28-12-10-27(4-2)11-13-28/h3-4,6-7,14-15,17,28H,2,5,8-13,16H2,1H3;3-4,6-7,14,16,27H,2,5,8-13,15H2,1H3,(H,28,29,30);5-6,8-9,16-17,24H,3-4,7,10-15H2,1-2H3,(H,25,26,27);5-6,8-9,16-17,24H,3-4,7,10-15H2,1-2H3.
What are the key properties of 1-[5-(4-ethylpiperazin-1-yl)-1,3,4-thiadiazol-2-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;1-[3-(4-ethylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1,3-oxazol-5-yl]hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[3-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one?
1-[5-(4-ethylpiperazin-1-yl)-1,3,4-thiadiazol-2-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;1-[3-(4-ethylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1,3-oxazol-5-yl]hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[3-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one has a molecular weight of 1759.19 g/mol, XLogP of 17.33, 36 rotatable bonds, 6 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[5-(4-ethylpiperazin-1-yl)-1,3,4-thiadiazol-2-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;1-[3-(4-ethylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-3-(1H-indol-3-ylmethyl)hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1,3-oxazol-5-yl]hexan-1-one;3-(1H-indol-3-ylmethyl)-1-[3-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one is sourced from PubChem (CID 158616965), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).